Psychemedics Corporation Stock Split Announcement
Psychemedics Corporation (Nasdaq: PMD), renowned for its hair testing technology for drug detection, has recently revealed its decision to implement a substantial stock split following stockholder approval. This two-step process involves a reverse stock split ratio of 1-for-5,000 and is immediately followed by a forward stock split of 5,000-for-1. The effective timing for these changes is set for specific hours on a Tuesday, effectively allowing trading adjustments to begin the following Wednesday.
Details of the Stock Split Process
Under the terms laid out, stockholders holding fewer than 5,000 shares will receive a cash payment for their shares as part of the reverse stock split process. Those shares will be valued at $2.35 each, without interest. Notably, any stockholder with more than 5,000 shares will not receive any cash but will retain their stock in a one-to-one exchange following the forward stock split. This dual approach, namely the Reverse Stock Split and Forward Stock Split, means that, post-split, those continuing stockholders essentially maintain their shareholdings without changes in total quantity.
Role of Computershare Trust Company
In managing these transactions, Computershare Trust Company, N.A. has been appointed as the exchange and paying agent. Registered stockholders with electronically held shares will find the transition seamless, requiring no action on their part. For those holding shares through intermediaries such as brokers or banks, adjustments will occur automatically in accordance with the broker's processes.
Rationale Behind the Stock Split
The primary objective of Psychemedics Corporation in executing this stock split relates to its strategy for potential delisting from The Nasdaq Stock Market. This action is intended to reduce the extensive costs associated with being a publicly listed company. The expected savings from these adjustments are substantial, projected to exceed $845,000 annually. In making this strategic move, the Company's leadership plans to reallocate resources towards enhancing operational efficiencies and exploring innovative business initiatives that promise significant long-term growth. This focus is anticipated to bolster stockholder value and streamline operations moving forward.
About Psychemedics Corporation
Psychemedics Corporation is a leader in drug testing technology, primarily utilizing hair samples to detect abuse. Their patented testing procedure serves a wide array of clients, including significant corporations among the Fortune 500, law enforcement agencies, educational institutions, and various public sectors reliant on dependable drug testing methods. The Company’s approach is increasingly viewed as superior to traditional urine testing methods, spotlighting its commitment to high-quality standards and innovation in drug detection technology.
Contact Information
For further inquiries, the investor relations contact at Psychemedics Corporation can be reached:
Daniella Mehalik
VP of Finance
(800) 628-8073
DaniellaM@psychemedics.com
Frequently Asked Questions
What is the reason for Psychemedics Corporation's stock split?
The stock split aims to facilitate a potential delisting from Nasdaq and reduce the costs associated with being a public company, while allowing the leadership to focus on the business.
How will the stock split affect existing shareholders?
Shareholders holding fewer than 5,000 shares will receive cash for their shares, while those with more than 5,000 shares will retain their full holdings post-split.
What are the specific ratios for the stock split?
The split includes a 1-for-5,000 reverse stock split followed by a 5,000-for-1 forward stock split.
When will the stock split take effect?
The stocks will undergo the split process on a Tuesday, with trading adjustments starting the following Wednesday.
Who is managing the stock split transactions?
Computershare Trust Company, N.A. has been designated as the exchange and paying agent for the stock split process.
